214 related articles for article (PubMed ID: 34903448)
41. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
[TBL] [Abstract][Full Text] [Related]
42. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study.
Rivera-Izquierdo M; Láinez-Ramos-Bossini AJ; de Alba IG; Ortiz-González-Serna R; Serrano-Ortiz Á; Fernández-Martínez NF; Ruiz-Montero R; Cervilla JA
BMC Med; 2022 Feb; 20(1):92. PubMed ID: 35193574
[TBL] [Abstract][Full Text] [Related]
43. "Long COVID" results after hospitalization for SARS-CoV-2 infection.
Rigoni M; Torri E; Nollo G; Donne LD; Rizzardo S; Lenzi L; Falzone A; Cozzio S
Sci Rep; 2022 Jun; 12(1):9581. PubMed ID: 35688830
[TBL] [Abstract][Full Text] [Related]
44. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge.
Fortini A; Torrigiani A; Sbaragli S; Lo Forte A; Crociani A; Cecchini P; Innocenti Bruni G; Faraone A
Infection; 2021 Oct; 49(5):1007-1015. PubMed ID: 34091869
[TBL] [Abstract][Full Text] [Related]
45. Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study at a primary care referred outpatient clinic in Helsinki, Finland.
Virrantaus H; Liira H; Posharina T; Sulg A; Mäntylä T; Kanerva M; Laakso S; Sainio M; Malmivaara A; Vuokko A; Varonen M; Venäläinen M; Arokoski J
BMJ Open; 2023 Oct; 13(10):e072935. PubMed ID: 37848295
[TBL] [Abstract][Full Text] [Related]
46. Predictors of post COVID complications in patients admitted with moderate to severe COVID symptoms: A single center, prospective, observational study.
Guliani A; Tandon A; Chakroborty A; Gupta PP
Monaldi Arch Chest Dis; 2022 Jul; 93(2):. PubMed ID: 35872628
[TBL] [Abstract][Full Text] [Related]
47. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
Fründt T; Kuballa L; Lütgehetman M; Nörz D; Arend H; Brehm TT; Schulze Zur Wiesch J; Horvatits T; Horvatits K; Huber S; Wege H; Kluwe J
PLoS One; 2021; 16(12):e0258450. PubMed ID: 34941875
[TBL] [Abstract][Full Text] [Related]
48. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Ghosn J; Piroth L; Epaulard O; Le Turnier P; Mentré F; Bachelet D; Laouénan C;
Clin Microbiol Infect; 2021 Jul; 27(7):1041.e1-1041.e4. PubMed ID: 34125067
[TBL] [Abstract][Full Text] [Related]
49. Long COVID in a prospective cohort of home-isolated patients.
Blomberg B; Mohn KG; Brokstad KA; Zhou F; Linchausen DW; Hansen BA; Lartey S; Onyango TB; Kuwelker K; Sævik M; Bartsch H; Tøndel C; Kittang BR; ; Cox RJ; Langeland N
Nat Med; 2021 Sep; 27(9):1607-1613. PubMed ID: 34163090
[TBL] [Abstract][Full Text] [Related]
50. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal study of changes observed in quality of life, psychological state cognition and pulmonary and functional capacity after COVID-19 infection: A six- to seven-month prospective cohort.
Del Corral T; Menor-Rodríguez N; Fernández-Vega S; Díaz-Ramos C; Aguilar-Zafra S; López-de-Uralde-Villanueva I
J Clin Nurs; 2024 Jan; 33(1):89-102. PubMed ID: 35534994
[TBL] [Abstract][Full Text] [Related]
52. Assessment of Post-Covid Symptoms in Covid-19 Recovered Patients: A Prospective Cohort Study in a Tertiary Care Centre of South India.
Kambhampati NT; Chithira ; PillaiM GK; Ts D; Moni M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443500
[TBL] [Abstract][Full Text] [Related]
53. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination.
Vanichkachorn G; Gilman E; Ganesh R; Mueller M; Swift M; Breeher L; Murad MH
J Investig Med; 2023 Dec; 71(8):889-895. PubMed ID: 37497990
[TBL] [Abstract][Full Text] [Related]
54. Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors.
Fernández-de-Las-Peñas C; Ryan-Murua P; Rodríguez-Jiménez J; Palacios-Ceña M; Arendt-Nielsen L; Torres-Macho J
Respiration; 2022; 101(7):658-665. PubMed ID: 35381597
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months' follow-up.
Petersen MS; Kristiansen MF; Hanusson KD; Foldbo BM; Danielsen ME; Á Steig B; Gaini S; Strøm M; Weihe P
Int J Infect Dis; 2022 Sep; 122():437-441. PubMed ID: 35753603
[TBL] [Abstract][Full Text] [Related]
56. Prognosis of patients with post-Covid-19 condition: Prospective cohort cluster analysis at one year.
Liira H; Garner P; Malmivaara A; Kanerva M; Kvarnström K; Sainio M; Varonen M; Venäläinen M; Vuokko A; Arokoski J
J Psychosom Res; 2024 Jul; 182():111808. PubMed ID: 38781803
[TBL] [Abstract][Full Text] [Related]
57. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
[TBL] [Abstract][Full Text] [Related]
58. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital.
Fink TT; Marques HHS; Gualano B; Lindoso L; Bain V; Astley C; Martins F; Matheus D; Matsuo OM; Suguita P; Trindade V; Paula CSY; Farhat SCL; Palmeira P; Leal GN; Suzuki L; Odone Filho V; Carneiro-Sampaio M; Duarte AJS; Antonangelo L; Batisttella LR; Polanczyk GV; Pereira RMR; Carvalho CRR; Buchpiguel CA; Xavier ACL; Seelaender M; Silva CA; Pereira MFB; ; Sallum AME; Brentani AVM; Neto ÁJS; Ihara A; Santos AR; Canton APM; Watanabe A; Santos ACD; Pastorino AC; Franco BDGM; Caruzo B; Ceneviva C; Martins CCMF; Prado D; Abellan DM; Benatti FB; Smaria F; Gonçalves FT; Penteado FD; Castro GSF; Gonçalves GS; Roschel H; Disi IR; Marques IG; Castro IA; Buscatti IM; Faiad JZ; Fiamoncini J; Rodrigues JC; Carneiro JDA; Paz JA; Ferreira JC; Ferreira JCO; Silva KR; Bastos KLM; Kozu K; Cristofani LM; Souza LVB; Campos LMA; Silva Filho LVRF; Sapienza MT; Lima MS; Garanito MP; Santos MFA; Dorna MB; Aikawa NE; Litvinov N; Sakita NK; Gaiolla PVV; Pasqualucci P; Toma RK; Correa-Silva S; Sieczkowska SM; Imamura M; Forsait S; Santos VA; Zheng Y
Clinics (Sao Paulo); 2021; 76():e3511. PubMed ID: 34852145
[TBL] [Abstract][Full Text] [Related]
59. Long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalisation.
Battistella LR; Imamura M; De Pretto LR; Van Cauwenbergh SKHAA; Delgado Ramos V; Saemy Tome Uchiyama S; Matheus D; Kuhn F; Amaral de Oliveira AA; Souza Naves G; Rossetti Mirisola A; de Quadros Ribeiro F; Tadeu Sugawara A; Cantarino M; Andrade Santos Antunes Cavalca R; Pagano V; Valentim Marques M; Mendes da Silva E; Pereira Gomes A; Fregni F
BMJ Open; 2022 Jul; 12(7):e057246. PubMed ID: 35896292
[TBL] [Abstract][Full Text] [Related]
60. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.
Mahmud R; Rahman MM; Rassel MA; Monayem FB; Sayeed SKJB; Islam MS; Islam MM
PLoS One; 2021; 16(4):e0249644. PubMed ID: 33831043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
